Mitochondrial DNA variation and HIV-associated sensory neuropathy in CHARTER.

TitleMitochondrial DNA variation and HIV-associated sensory neuropathy in CHARTER.
Publication TypeJournal Article
Year of Publication2012
AuthorsHolzinger, ER, Hulgan, T, Ellis, RJ, Samuels, DC, Ritchie, MD, Haas, DW, Kallianpur, AR, Bloss, CS, Clifford, DB, Collier, AC, Gelman, BB, Marra, CM, McArthur, JC, J McCutchan, A, Morgello, S, Simpson, DM, Franklin, DR, Rosario, D, Selph, D, Letendre, S, Grant, I
Corporate AuthorsCHARTER Group
JournalJ Neurovirol
Date Published2012 Dec
KeywordsAdult, African Continental Ancestry Group, CHARTER, DNA, Mitochondrial, European Continental Ancestry Group, Female, Haplotypes, HIV Infections, HIV-1, Humans, Internal, Male, Middle Aged, Mitochondria, Polymorphism, Single Nucleotide, Polyneuropathies, Prospective Studies

HIV-associated sensory neuropathy remains an important complication of combination antiretroviral therapy and HIV infection. Mitochondrial DNA haplogroups and single nucleotide polymorphisms (SNPs) have previously been associated with symptomatic neuropathy in clinical trial participants. We examined associations between mitochondrial DNA variation and HIV-associated sensory neuropathy in CNS HIV Antiretroviral Therapy Effects Research (CHARTER). CHARTER is a USA-based longitudinal observational study of HIV-infected adults who underwent a structured interview and standardized examination. HIV-associated sensory neuropathy was determined by trained examiners as ≥1 sign (diminished vibratory and sharp-dull discrimination or ankle reflexes) bilaterally. Mitochondrial DNA sequencing was performed and haplogroups were assigned by published algorithms. Multivariable logistic regression of associations between mitochondrial DNA SNPs, haplogroups, and HIV-associated sensory neuropathy were performed. In analyses of associations of each mitochondrial DNA SNP with HIV-associated sensory neuropathy, the two most significant SNPs were at positions A12810G [odds ratio (95 % confidence interval) = 0.27 (0.11-0.65); p = 0.004] and T489C [odds ratio (95 % confidence interval) = 0.41 (0.21-0.80); p = 0.009]. These synonymous changes are known to define African haplogroup L1c and European haplogroup J, respectively. Both haplogroups were associated with decreased prevalence of HIV-associated sensory neuropathy compared with all other haplogroups [odds ratio (95 % confidence interval) = 0.29 (0.12-0.71); p = 0.007 and odds ratio (95 % confidence interval) = 0.42 (0.18-1.0); p = 0.05, respectively]. In conclusion, in this cohort of mostly combination antiretroviral therapy-treated subjects, two common mitochondrial DNA SNPs and their corresponding haplogroups were associated with a markedly decreased prevalence of HIV-associated sensory neuropathy.

Alternate JournalJ. Neurovirol.
PubMed ID23073667
PubMed Central IDPMC3587171
Grant ListHHSN271201000030C / MH / NIMH NIH HHS / United States
T32 GM080178 / GM / NIGMS NIH HHS / United States
HHSN271201000030C / / PHS HHS / United States
HHSN271201000027C / / PHS HHS / United States
N01MH22005 / MH / NIMH NIH HHS / United States
HHSN271201000027C / MH / NIMH NIH HHS / United States
N01 MH022005 / MH / NIMH NIH HHS / United States